SCHEMBL14798477

SCHEMBL14798477

C=C(C)C(=O)Oc1ccc(C2(c3ccc(OC)cc3)c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.49
MAPT P10636 4/20 0.43
KMT2A Q03164 5/20 0.42
NPC1 O15118 1/20 0.42
MAPK1 P28482 1/20 0.42
RAB9A P51151 1/20 0.42
ATM Q13315 1/20 0.40
MEN1 O00255 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
OPRK1 P41145 1/20 0.40
POLB P06746 2/20 0.39
GAA P10253 2/20 0.39
ALDH1A1 P00352 1/20 0.38
HTT P42858 1/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
PDK2 Q15119 3/20 0.37
KIF11 P52732 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479174 0.95 ELANE (0.54) ELANEMAPTKMT2ANPC1MAPK1
SCHEMBL3017740 0.90 ELANE (0.49) ELANEMAPTKMT2AATMMEN1
SCHEMBL16900316 0.87 MAPT (0.40) ELANEMAPTKMT2ANPC1MAPK1
SCHEMBL13583090 0.86 MAPT (0.57) ELANEMAPTKMT2ANPC1MAPK1
SCHEMBL23442222 0.86 ELANE (0.46) ELANEMAPTKMT2AATMMEN1
SCHEMBL19408190 0.86 ELANE (0.46) ELANEMAPTKMT2ANPC1RAB9A
SCHEMBL12282382 0.85 ELANE (0.45) ELANEMAPTKMT2AATMMEN1
SCHEMBL15356193 0.84 ESR1 (0.48) ELANEMAPTKMT2AATMMEN1
SCHEMBL16137609 0.83 ELANE (0.45) ELANEMAPTKMT2ANPC1RAB9A
SCHEMBL22648038 0.83 KMT2A (0.43) MAPTKMT2ANPC1MAPK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718580-B2 Fluorene derivatized monomers and polymers for volume Bragg gratings META PLATFORMS TECHNOLOGIES, LLC (US) 2023-08-08 US disclosed
US-11718580-B2 Fluorene derivatized monomers and polymers for volume Bragg gratings META PLATFORMS TECHNOLOGIES, LLC (US) 2023-08-08 US disclosed
US-11718580-B2 Fluorene derivatized monomers and polymers for volume Bragg gratings META PLATFORMS TECHNOLOGIES, LLC (US) 2023-08-08 US disclosed
EP-3966195-B1 FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS FACEBOOK TECH LLC (US) 2023-07-05 EP disclosed
EP-3966195-B1 FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS FACEBOOK TECH LLC (US) 2023-07-05 EP disclosed
US-20200354311-A1 FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS META PLATFORMS TECHNOLOGIES, LLC 2020-11-12 US disclosed
US-20200354311-A1 FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS META PLATFORMS TECHNOLOGIES, LLC 2020-11-12 US disclosed
WO-2020227264-A1 FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS FACEBOOK TECHNOLOGIES, LLC (US) 2020-11-12 WO disclosed
US-8916053-B2 Pattern forming method KABUSHIKI KAISHA TOSHIBA (JP) 2014-12-23 US disclosed
US-20130075361-A1 PATTERN FORMING METHOD KABUSHIKI KAISHA TOSHIBA (JP) 2013-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200354311-A1 FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS RHOA, PARG, LSG1 ELANE 2179/4885MAPT 2962/4885KMT2A 547/4885
US-11718580-B2 Fluorene derivatized monomers and polymers for volume Bragg gratings RHOA, PARG, LSG1 ELANE 2179/4885MAPT 2962/4885KMT2A 547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.